Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/orexo-publishes-the-annual-and-sustainability-report-for-2023-302102281.html
https://www.prnewswire.com/news-releases/notice-of-annual-general-meeting-of-orexo-302090268.html
https://www.prnewswire.com/news-releases/orexo-successfully-issues-senior-secured-callable-floating-rate-social-bonds-of-sek-500-m-and-announces-results-of-the-tender-offer-for-its-existing-bonds-302088572.html
https://www.prnewswire.com/news-releases/orexo-strengthens-its-sustainability-work-by-establishing-a-social-financing-framework-302083869.html
https://www.prnewswire.com/news-releases/orexo-contemplates-issuance-of-senior-secured-callable-floating-rate-social-bonds-and-announces-a-conditional-tender-offer-for-its-existing-bonds-302083868.html
https://www.prnewswire.com/news-releases/orexo-and-sobi-agree-to-advance-feasibility-study-with-amorphox-302059365.html
https://www.prnewswire.com/news-releases/orexo-interim-report-q4-2023-incl-full-year-report-302057222.html
https://www.prnewswire.com/news-releases/orexos-ox640-development-results-to-be-presented-at-the-2024-aaaai-annual-meeting-in-washington-dc-302054263.html
https://www.prnewswire.com/news-releases/orexo-announces-fda-acceptance-of-new-drug-application-filing-for-ox124-a-high-dose-rescue-medication-for-opioid-overdose-301998807.html
https://www.prnewswire.com/news-releases/orexo-q3-2023-interim-report-301975389.html